Reply to P. Boffetta and M. Seyyedsalehi

Thilagavathi Ramamoorthy1, Anita Nath1, Shubhra Singh1

  • 1Thilagavathi Ramamoorthy, PhD, Indian Council of Medical Research-National Centre for Disease Informatics and Research, Bengaluru, India; Anita Nath, MD, Indian Council of Medical Research-National Centre for Disease Informatics and Research, Bengaluru, India; Shubhra Singh, PhD, Indian Council of Medical Research-National Centre for Disease Informatics and Research, Bengaluru, India; Stany Mathew, MPH, Indian Council of Medical Research-National Centre for Disease Informatics and Research, Bengaluru, India; Apourv Pant, PhD, Indian Council of Medical Research-National Centre for Disease Informatics and Research, Bengaluru, India; Samvedana Sheela, MD, Indian Council of Medical Research-National Centre for Disease Informatics and Research, Bengaluru, India; Gurpreet Kaur, MSc, Indian Council of Medical Research-National Centre for Disease Informatics and Research, Bengaluru, India; Krishnan Sathishkumar, MSc, Indian Council of Medical Research-National Centre for Disease Informatics and Research, Bengaluru, India; Prashant Mathur, PhD, DNB, Indian Council of Medical Research-National Centre for Disease Informatics and Research, Bengaluru, India.

JCO Global Oncology
|October 24, 2024
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is: